Ligand Pharmaceuticals
LGND
#4061
Rank
NZ$3.92 B
Marketcap
$207.96
Share price
1.11%
Change (1 day)
121.76%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.67. In 2022 the company made an earnings per share (EPS) of -$3.37 a decrease over its 2021 EPS that were of $5.89.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-175.15%
2022-$3.37-157.23%
2021$5.89-2571.43%
2020-$0.24-100.46%
2019$52.14353.48%
2018$11.501025%
2017$1.02-700%
2016-$0.17-100.87%
2015$19.691859.32%
2014$1.015.36%
2013$0.958.0704505322479E+18%
2012$0.0000000000-100%
2011$0.83-194.23%
2010-$0.89548.38%
2009-$0.14-98.7%
2008-$10.53-136.52%
2007$28.82-787.8%
2006-$4.19-14.58%
2005-$4.91-21.31%
2004-$6.23-55.15%
2003-$13.9081.33%
2002-$7.672.74%
2001-$7.46-45.93%
2000-$13.80-14.56%
1999-$16.15-45.52%
1998-$29.64-3.97%
1997-$30.87132.31%
1996-$13.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.10 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.61-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.96 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.10 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.17 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.25 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.76 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.72 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.99 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA